AaronFrancisJollyMDFACC FASNC

Nuclear Cardiology

Cardiologist

Dr. Jolly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of California (Irvine)Fellowship, Cardiovascular Disease, 2013 - 2016
University of California (Irvine)Residency, Internal Medicine, 2011 - 2013
Lahey ClinicInternship, Internal Medicine, 2010 - 2011
Royal College of Surgeons IrelandClass of 2009
Cornell UniversityB.S., Biological Engineering, 2000 - 2003
Upper Canada CollegeDiploma, International Baccalaureate, 1994 - 1999

PubMed

6 citations
Intravenous caffeine: An alternative to aminophylline to reverse adverse effects during regadenoson myocardial perfusion imaging
Aaron F Jolly, Gregory S. Thomas
Journal of Nuclear Cardiology. 2017-06-01
3 citations
When to re-dose regadenoson?
Gregory S. Thomas, Aaron F. Jolly, Michael Safani
Journal of Nuclear Cardiology. 2017-02-01
14 citations
Same-day discharge after coronary stenting and femoral artery device closure: A randomized study in stable and low-risk acute coronary syndrome patients ☆
Leonardo C. Clavijo, Guillermo A. Cortes, Aaron Jolly, Han Tun, Anilkumar Mehra
Cardiovascular Revascularization Medicine. 2016-04-01

Journal Articles

Thromboangiitis Obliterans
Jolly AF, Patel PM, Ferri’s Clinical Advisor, 1/1/2016
Claudication
Jolly AF, Patel PM, Ferri’s Clinical Advisor, 1/1/2016
When to re-dose regadenoson?
Thomas GS, Jolly AF, Safani M, Journal of Nuclear Cardiology, 1/1/2015
Ultrasound-guided Venous Access for Pacemakers and Defibrillators
Seto AH, Jolly AF, Salcedo J, Journal of Cardiovascular Electrophysiology, 1/1/2013
PICA aneurysms: case report and review of literature
A Jolly, S Gupta, RCSI SMJ, 1/1/2008
Angiogenesis Following Three-Dimensional Culture of Isolated Human Endometrial Stromal Cells
Esfandiari N, Khazael M, Al J, Nazemian Z, Jolly AF, Casper RF, International Journal of Fertility and Sterility, 1/1/2008
Join now to see all

Abstracts/Posters

Women’s Heart disease: Introducing coronary microvascular dysfunction testing in an academic cardiac catheterization laboratory
Jolly AF, Malik S, Patel PM, ACP Southern California Chapter poster competition, Orange, CA, 1/1/2014
An Unusual Consequence of Bacillus Calmette-Guérin Therapy
Mohanty GP, Mirbach BE, Duggirala V, Jolly AF, Tsapatsaris N, Research poster presentation, Lahey Clinic, Burlington, MA, 1/1/2012
High Risk PCI Supported By Left Ventricular Hemodynamic Assist Devices: A Comparison of the Tandem Heart and Impella 2.5
Chen SF, Jolly AF, Somma K, Chana A, Shavelle D, Mehra A, Clavijo LC, Matthews R, Cardiovascular Research Technologies Annual Meeting, Washington, DC, 1/21/2010
High Risk Percutaneous Coronary Intervention with Hemodynamic Assist Devices: the Role of Angiographic and Clinical Scoring Systems in Predicting Outcome
Chen SF, Jolly AF, Shavelle D, Mehra A, Clavijo LC, Matthews R, The Society for Cardiovascular Angiography and Interventions Annual Scientific Sessions, San Diego, CA, 1/5/2010
Join now to see all